(Q61920686)
Statements
A Randomized, Open-Label, Controlled, Phase II Trial of Combination Chemotherapy With or Without Panitumumab as First-line Treatment of Subjects With Metastatic or Recurrent Head and Neck Cancer, and Cross-over Second-line Panitumumab Monotherapy of Subjects Who Fail the Combination Chemotherapy… (English)
0 references
1 January 2007
0 references
11 June 2012
0 references
113
0 references
18 year
0 references
70 year
0 references